Neil McLoughlin
Consejero General en DATALEX PLC .
Fortuna: 79 728 $ al 31/05/2024
Cargos activos de Neil McLoughlin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| DATALEX PLC | Consejero General | 23/08/2019 | - |
| Secretario Corporativo | 23/08/2019 | - |
Historial de carrera de Neil McLoughlin
Antiguos cargos conocidos de Neil McLoughlin.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MALIN CORPORATION PLC | Director de Operaciones | 01/01/2015 | 01/11/2018 |
| Consejero General | 01/01/2015 | - | |
| Secretario Corporativo | 01/01/2015 | - | |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Irlanda | 4 |
Operativa
| Corporate Secretary | 2 |
| General Counsel | 2 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 3 |
| Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MALIN CORPORATION PLC | Health Technology |
| DATALEX PLC | Technology Services |
| Empresas privadas | 1 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Neil McLoughlin
- Experiencia
